LEADER 00000cam a2200625Ia 4500 001 ocm38160933 005 20090716161427.0 008 980203s1997 mdua b f101 0 eng d 020 |c$20.00 035 (OCoLC)38160933 035 (GPO)apn98-008348 035 290703 037 017-024-01612-8|bGPO 040 MMU|beng|cMMU|dGPO|dCNO 049 RIDM 074 0831-C-12 074 0831-C-12 (online) 086 0 HE 20.3965:175 090 HV5810 .M42 1997 096 WM 280 .M489 1997 245 00 Medication development for the treatment of cocaine dependence :|bissues in clinical efficacy trials / |ceditors, Betty Tai, Nora Chiang, Peter Bridge. 264 1 Rockville, MD :|bU.S. Dept. of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Office of Science Policy and Communications ; |a[Washington, D.C.] :|b[Supt. of Docs., U.S. G.P.O., distributor],|c1997. 300 iv, 329 pages :|billustrations ;|c24 cm. 336 text|btxt|2rdacontent 337 unmediated|bn|2rdamedia 338 volume|bnc|2rdacarrier 490 1 NIDA research monograph ;|v175 490 1 NIH publication ;|vno. 98-4125 500 "Based on the papers from a technical review ... held on October 20-21, 1994"--p. ii. 500 Shipping list no.: 98-0092-P. 504 Includes bibliographical references. 505 0 Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research -- Overview of potential treatment medications for cocaine dependence -- Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective -- Management of clinical trials with new medications for cocaine dependence and abuse -- Outcome measurement considerations : pharmacological treatments for substance abuse -- Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials -- Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence -- Addiction severity index in clinical efficacy trials of medications for cocaine dependence -- Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment -- Treatment effectiveness score as an outcome measure in clinical trials -- Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis -- Quantitative urine levels of cocaine and other substances of abuse -- Use of quantitative urinalysis in monitoring cocaine use -- Is quantitative urinalysis more sensitive? -- Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine -- Appendix I: Workshop summary outcome measures and success criteria -- Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy. 530 Also available via Internet from the NIDA web site (PDF file only). 650 0 Cocaine abuse|0https://id.loc.gov/authorities/subjects/ sh85027560|xChemotherapy|0https://id.loc.gov/authorities/ subjects/sh99004980|vCongresses.|0https://id.loc.gov/ authorities/subjects/sh99001533 650 0 Cocaine abuse|xTreatment|0https://id.loc.gov/authorities/ subjects/sh2009120532|vCongresses.|0https://id.loc.gov/ authorities/subjects/sh99001533 650 0 Clinical trials|0https://id.loc.gov/authorities/subjects/ sh85027069|vCongresses.|0https://id.loc.gov/authorities/ subjects/sh99001533 650 7 Cocaine abuse.|2fast|0https://id.worldcat.org/fast/1430058 650 7 Chemotherapy.|2fast|0https://id.worldcat.org/fast/853595 650 7 Cocaine abuse|xTreatment.|2fast|0https://id.worldcat.org/ fast/1430071 650 7 Clinical trials.|2fast|0https://id.worldcat.org/fast/ 864429 655 7 Conference papers and proceedings.|2lcgft|0https:// id.loc.gov/authorities/genreForms/gf2014026068 655 7 Conference papers and proceedings.|2fast|0https:// id.worldcat.org/fast/1423772 700 1 Tai, Betty.|0https://id.loc.gov/authorities/names/ no98067037 700 1 Chiang, C. Nora.|0https://id.loc.gov/authorities/names/ n85232645 700 1 Bridge, Peter.|0https://id.loc.gov/authorities/names/ no2012082025 710 2 National Institute on Drug Abuse.|bOffice of Science Policy and Communications.|0https://id.loc.gov/authorities /names/no97061985 830 0 NIDA research monograph ;|0https://id.loc.gov/authorities/ names/n42017618|v175. 830 0 NIH publication ;|0https://id.loc.gov/authorities/names/ n84710198|vno. 98-4125. 856 7 |uhttp://www.nida.nih.gov/pdf/monographs/monograph175/ download175.html|2http|zAdobe Acrobat Reader required to view full document|zURL accesses introductory page, from which a link may be made to the full document 901 MARCIVE 20231220 935 290703
|